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valescence) was found. Five weeks postoperatively, 58.7% 
(RP) vs. 25.8% (OP) were fully convalescent compared to 
87.0% (RP) vs. 71.0% (OP) at 8 weeks. Similarly, 58.7 vs. 45.1% 
returned work 5 weeks postoperatively while 93.5 vs. 74.2% 
did so after 8 weeks, respectively. The small sample size, 
more questions on satisfaction/regret and mixed design are 
the main study limitations.  Conclusion: RP provides the 
same functional results beside earlier convalescence, better 
HRQoL and patients’ convenience with surgery, which fa-
vours its inclusion in preoperative counselling providing pa-
tients with realistic postoperative expectations.
 Copyright © 2013 S. Karger AG, Basel
 Introduction
 Pyeloplasty is the standard surgery for ureteropelvic 
junction obstruction (UPJO) aiming to relieve symptoms 
and/or to preserve remaining renal function. Despite the 
high success rate (>95%) of open pyeloplasty (OP)  [1] , 
minimally invasive techniques have been developed to 
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 Abstract
 Purpose: To report postoperative health-related quality of 
life (HRQoL) and patients’ subjective evaluations of open py-
eloplasty (OP) and retroperitoneoscopic pyeloplasty (RP) 
and influences on preoperative counselling.  Methods: 107 
patients (age 16–80 years, mean 31.5) with symptomatic pri-
mary ureteropelvic junction obstruction who underwent OP 
(32) or RP (75) were evaluated prospectively. HRQoL was 
evaluated using Short Form 36 (SF-36) questionnaires with 
1 year follow-up. Operative outcomes were evaluated using 
a self-designed questionnaire regarding cosmetic outcomes, 
objective postoperative/current pain, convalescence and re-
turn to work.  Results: The mean operative time was 174.4 vs. 
161.4 min for RP versus OP, respectively, without intraopera-
tive complications/conversions. There was an advantage for 
RP – except for two domains – without significance in any of 
the eight SF-36 domain scores. An advantage favouring RP 
in all aspects of the second questionnaire with significance 
in four aspects (cosmetic results, scar length, pain and con-
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lower its morbidity since the first successful OP reported 
by Kuster in 1891  [2] .
 Laparoscopic pyeloplasty (LP), initially reported by 
Kavoussi, has proved to be a safe and effective treatment 
for UPJO  [3–5] . Retroperitoneoscopic pyeloplasty (RP) 
has evolved synchronously to LP with a success rate com-
parable to LP and OP  [5] . The technique of LP/RP has 
been simplified over the years. Rising experience with this 
technique has made it safer, reproducible and standard-
ized. The learning curve has become significantly shorter 
as more surgeons are familiar with these techniques  [6–
11] .
 Health-related quality of life (HRQoL) has become a 
major parameter in evaluating the outcome of a treat-
ment and even constitutes a main criterion when choos-
ing among different interventions with similar efficacy 
and morbidity  [12] . The current study aims to compare 
surgical outcomes, HRQoL and patients’ subjective eval-
uations of both standard approaches (OP and RP) to de-
tect possible benefits of the procedures from the patients’ 
point of view. This may be an addition to the preoperative 
counselling of these patients.
 Patients and Methods
 Patients
 A total of 107 consecutive patients (64 male and 43 female, age 
16–80 years, mean 31.5 years) with symptomatic primary UPJO, 
who underwent OP or RP, were evaluated for postoperative pa-
rameters and HRQoL. The surgical approach was OP (32 patients) 
and RP (75 patients), performed at the University Hospital of Basel 
(Switzerland) and the Ludwig Maximilian University Hospital in 
Munich (Germany). Both centres equally shared the patient col-
lective. UPJO was treated in the left (72 cases) and right side (35 
patients). OP was done according to patients’ preference or before 
our experience with RP without any selection. Patients character-
istics are presented in  table 1 .
 Patients were assessed preoperatively by routine laboratory pa-
rameters, retrograde/intravenous pyelography and diuretic renog-
raphy using  99 Tc mercaptoacetyltriglycine. All cases had one or 
more specific criteria of hugely dilated pelvis (42.0% 2nd and 3rd 
grade, 45/107), crossing vessels at the ureteropelvic junction 
(36.4%, 39/107) and/or compromised function of the affected kid-
ney. Patients were operated retroperitoneally (open or endoscop-
ic) under combined general and epidural anaesthesia.
 Operative Data
 The procedures were performed as described in the literature 
 [6, 10] . The patient was placed in a lateral position for both ap-
proaches. A flank lateral incision was used for the open approach. 
The skin and subcutaneous tissues were incised over tip of the 12th 
rib, extending along the superior border of the 12th rib ( ≈ 8 cm). 
The latissimus dorsi, external oblique and internal oblique muscles 
were transected and the transversus abdominis was divided in the 
direction of its fibres with preservation of the intercostal neurovas-
cular bundle. The transversalis fascia was divided with scissors 
near the tip of the 12th rib followed by blunt dissection of the peri-
toneum from the anterior abdominal wall. The Bookwalter TM  re-
tractor (Codman & Shurtleff, Inc., Raynham, Mass., USA) was 
placed to retract the incision (11th rib and rib cage superiorly and 
12th rib and abdominal wall inferiorly). The retroperitoneal space 
was then developed through blunt and sharp dissection and the 
kidney with its surrounding soft tissues was reflected medially. The 
renal pelvis with the proximal ureter were then identified and dis-
sected.
 For the retroperitoneal approach, a 1-cm incision was made at 
the tip of last rib along the mid axillary line. The external, internal 
oblique and transversus abdominis muscle fibres were bluntly sep-
arated with a Kocher clamp. After the peritoneum had been digi-
tally dissected medially from the abdominal wall and dorsally from 
the psoas muscle, a balloon made from the middle finger of a size 
8 surgical glove and tied to the top of a 12-mm trocar was placed 
in the retroperitoneal space and inflated with 500–700 ml of saline 
to produce a working space. Inflation was maintained for a couple 
of minutes to allow haemostasis. In this manner, a working space 
to the upper retroperitoneum was obtained. The balloon was re-
moved and the trocar was fixed in place using a 0 nylon suture to 
prevent carbon dioxide leakage. Carbon dioxide insufflation at a 
pressure of 13 mm Hg was started to maintain the working space 
and diagnostic laparoscopy using a 30° optic was done. The peri-
toneum was dissected from the anterior abdominal wall using the 
optic to insert another port (12 mm for right-side or 5 mm to left-
side pyeloplasty) in the anterior axillary line 2–3 cm above and 
medial to the anterior superior iliac spine. The second working 
port was made 1 cm from the middle point of the line between both 
ports. The whole procedure was done through these two ports.
 The principle of Anderson-Hynes pyeloplasty was applied in 
all cases with trimming of redundant renal pelvis. Ureteropelvic 
re-anastomosis was performed by intracorporeal free hand con-
tinuous suturing using 4-0 polyglactin and laprotil clips  [8] . A 
7-French ureter stent was placed retrogradely only at beginning of 
the series and removed 2–8 weeks postoperatively (median 4.2 for 
OP and 4.8 for RP). In patients with renal stones, ureter stents were 
left in place until complete fragmentation of the calculi (n = 12). 
Patients started oral intake on the first postoperative day and the 
urethral catheter was removed after 2–5 days. The drainage tubes 
were removed after cessation of drainage/serous discharge. Op-
erative time (from introduction of the first port till closure of last 
port site), intraoperative and postoperative complications were re-
corded.
 Table 1.  Demography of the included OP and RP patients
 Characteristics  OP  RP 
 Number of patients  32  75 
 Average age, years  28.6 (16–74)  47.0 (16–80) 
 Sex, M/F  16/16  48/27 
 Side, left/right  10/22  61/14 
 Median operative time, min  161.4 (40–365)  174.4 (70–360) 




















   
   
   
   
   
   
   
   
   
   
   



























 HRQoL was evaluated using the Short Form 36 (SF-36) ques-
tionnaire with follow-up of 1 year. It has been specially validated 
for the German-speaking population (IQOLA-SF-36 German ver-
sion 1992) and has been used to evaluate possible body limitations 
through physical health problems, body pains, general health, vi-
tality, social functioning, emotional problems and mental health. 
The Mental Component Summary Score and the Physical Compo-
nent Summary Score are calculated according to a given SF-36 syn-
tax  [13] .
 Furthermore, operation-related outcomes were evaluated us-
ing a self-designed questionnaire. Patients were asked a set of 20 
questions (Q) regarding cosmetic outcomes (8Q), postoperative 
symptoms/complications (3Q), objective postoperative pain [early 
(3Q) and current situation (1Q)], convalescence (1Q), time to re-
turn to work (1Q), acceptance of operation (1Q), fluid intake (1Q) 
and follow-up intervals (1Q).
 Results
 Presenting symptoms were renal flank pain (49.5%, 
53/107), colic without evidence of nephrolithiasis (9.3%, 
10/107), recurrent pyelonephritis (15.9%, 17/107) and 
nephrolithiasis (12.0%, 13/107) while 13.0% (14/107) 
were asymptomatic.
 The diagnosis of anatomical/functional UPJO was 
documented preoperatively through abdominal ultra-
sound (107 patients, 100%), abdominal CT (32, 29.9%), 
MRI (5, 4.7%), intravenous pyelography (21, 19.6%) and 
retrograde pyelography (87, 81.3%). Renal scintigraphy 
revealed ipsilateral renal function of 19–24 in 7.5%, 25–29 
in 12.1%, 29–39 in 28.0%, 40–49 in 35.5% and >50 in 
16.8% of patients, respectively. Renal glomerular filtra-
tion rates as well as total function were within the age-
adapted normal range. Preoperative nephrostomy tube 
insertion was necessary in 2 emergency patients while a 
double-J ®  catheter was inserted electively.
 Operative time was 70–360 min (mean 174.4) and 40–
365 min (mean 161.4) with a median blood loss of 180 
and 160 ml for RP and OP, respectively. Crossing vessels 
(36.4%, 39/107), obstructing adhesions/ureteric scars 
(18.7%, 20/107) and primary UPJO (44.9%, 48/107) were 
found. Postoperative complications were ureter stent dis-
location (n = 1), temporary nephrostomy for hydrone-
phrosis (n = 1), which was successfully treated conserva-
tively without need of re-operation, and epididymitis 
(n = 1).
 77 patients (31 OP and 46 RP) returned their SF-36 
questionnaire. A standardized scale allowed the patients’ 
answers to be assigned to an individual domain score. 
This was translated to a scale of 0–100 (0 = very poor, 
100 = excellent). Clinical relevance starts from a differ-
ence of at least 20 points. Results are shown in  figure 1 
and  table 2 .
 An advantage in favour of RP was seen in six of eight 
domain scores (physical functioning, general health 
problems, vitality, social functioning, emotional role 
function, mental health). In two domains (limitations 
caused by physical health and bodily pains), the OP re-
sults were slightly better than those of RP. However, nei-
ther group showed any significant difference in any of 
SF-36 domain scores.
 Table 3 demonstrates all results of the second ques-
tionnaire. A large proportion of this questionnaire eval-
uated the cosmetic outcomes of surgery. 25.0% of pa-
tients claimed to be ‘concerned’ about cosmetic re-
sults preoperatively. 23.5% reported that this outcome 
played a ‘minor role’, and 51.5% were ‘not worried’ 
about the cosmetic result (19.6% of them reported that 
the importance of this issue increased over time postop-
eratively).
 Patients reported different grades of satisfaction re-
garding their cosmetic results: 26.0 vs. 22.5% ‘excellent’, 
39.1 vs. 35.5% ‘very good’, 19.6 vs. 19.4% ‘good’, 17.4 vs. 
9.7% ‘slightly bad’ and 2.2 vs. 9.7% ‘bad’ for RP versus OP, 
respectively. Furthermore, 50.0 vs. 48.4%, 39.1 vs. 22.6% 
and 3.2 vs. 10.9% of RP versus OP patients reported that 
they were ‘not disturbed’, ‘slightly disturbed’ and ‘dis-
turbed’ with their scars, respectively, while 0 vs. 25.8% 
reported to be ‘much disturbed’ for RP versus OP, respec-
tively.
 Postoperative scar length was reported to be between 
7 and 30 cm (average 13.9 cm) for OP. This was judged 
as ‘small’ (54.8%), ‘moderate’ (16.1%), ‘large’ (19.4%) 
and ‘very large’ (9.7%) by patients. The reported sum 
scar lengths of RP patients were between 2.5 and 7 cm 
(average 3.7 cm), which were judged as ‘small’ (60.9%), 
‘moderate’ (39.1%), ‘large’ (0%) and ‘very large’ (0%). 
Patients evaluated the location of their scar(s) as ‘not dis-
turbing’ (67.4 vs. 28.4%), ‘slightly disturbing’ (26.0 vs. 
25.8%) and ‘disturbing’ (4.3 vs. 22.6%) for RP versus OP, 
respectively.
 A second set of questions aimed to evaluate early/cur-
rent (1 year) postoperative pain. 45.7 vs. 16.1% of patients 
claimed that the operation was ‘not painful’, 32.6 vs. 
45.1% ‘slightly painful’, 13.0 vs. 16.1% ‘painful’, while 8.7 
vs. 22.7% judged it as ‘very painful’ for RP versus OP, re-
spectively. Surgical scars were reported by 69.6 vs. 67.7% 
as ‘painless’, 21.7 vs. 16.1% ‘slightly painful’, 8.7 vs. 16.1% 
‘painful’ and 0 vs. 0% ‘severely painful’ for RP and OP 
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asked to evaluate their pain level on a scale from 0 (‘abso-
lutely painless’) to 10 (‘severe pain’) ( fig. 2 ).
 Another question was whether patients felt increas-
ingly ill because of the operation. 4.3 vs. 12.9% answered 
‘yes’, 89.1 vs. 83.9% ‘no’ and 6.5 vs. 3.2% with ‘I do not 
know’ of RP versus OP patients.
 The last two questions aimed to find out how soon 
patients were fully convalescent postoperatively and 
when they were back to work. Five weeks postoperative-
ly, 58.7% (RP) vs. 25.8% (OP) of patients were fully con-
valescent compared to 87.0% (RP) vs. 71.0% (OP) at 
8  weeks. Similarly, 58.7 vs. 45.1% returned to work at 













 Physical functionality   89.1  17.5  87.1  19.8  90.5  15.7 
 Role limitations caused by physical health problems   79.9  37.2  82.1  35.9  78.4  37.9 
 Bodily pain   86.7  16.6  91.0  12.9  83.7  18.2 
 General health   71.8  20.5  64.2  15.5  76.8  21.8 
 Vitality   61.8  20.3  57.3  24.5  64.8  16.1 
 Social functioning   88.9  16.9  83.0  19.8  92.6  13.4 
 Role limitations caused by emotional problems  87.6  25.3  82.1  31.0  90.9  20.6 
 Mental health   71.9  16.6  66.7  17.6  75.4  14.9 
 The Mental Component Summary Scores were calculated. Scores per dimension range from 0 to 100; higher 















 Fig. 1. Results of the eight domain scores of the SF-36 in patients 
after OP and RP versus the total collective. PH = Physical function-
ality; RP = role limitations caused by physical health problems; 
BP = bodily pain; GH = general health; VT = vitality; SF = social 
functioning; RE = role limitation caused by emotional problems; 
MH = mental health. Furthermore the Mental Component Sum-
mary Scores were calculated. Scores per dimension range from 0 




































   
   
   
   
   
   
   
   
   
   
   


























 Table 3.  Results of the self-made life quality questionnaire in patients post RP versus OP
 Parameter/questions  RP versus OP 
 Cosmetic results 
 Excellent  Very good  Good  Slightly bad  Bad 
 How satisfied are you with the cosmetic 
 results of surgery? 
 
 26.0 vs. 22.5% 
 
 39.1 vs. 35.5% 
 
 19.6 vs. 19.4% 
 
 17.4 vs. 9.7% 
 
 2.2 vs. 9.7% 
 Not disturbed  Slightly disturbed  Disturbed  Much disturbed 
 Are you disturbed by your scar(s)?  50.0 vs. 48.4%  39.1 vs. 22.6%  3.2 vs. 10.9% 0 vs. 25.8% 
 Did the position of scar(s) disturb you?  67.4 vs. 28.4%  26.0 vs. 25.8%  4.3 vs. 22.6%  2.3 vs. 23.2% 
 Small  Moderate  Large  Very large 
 Did you think that your scar(s) are long?  60.9 vs. 54.8%  39.1 vs. 16.1%  0 vs. 19.4%  0 vs. 9.7% 
 Concerned  Minor role  Not worried 
 Were you concerned about the cosmetic 







 No  Little  More than little  Yes 
 Did cosmetic results become more important 
 to you with time postoperatively? 
 
 81.2 vs. 78.6% 
 
 18.2 vs. 14.3% 
 
 6.0 vs. 7.2% 
 
 0 vs. 0% 
 How long are your scars? (average in cm) 3.7 vs. 13.9 
 Pains 
 Painless  Slightly painful  Painful  Very painful 
 Did you have pains/complications early 
 postoperatively? 
 
 45.7 vs. 16.1% 
 
 32.6 vs. 45.1% 
 
 13.0 vs. 16.1% 
 
 8.7 vs. 22.7% 
 Was the operation a painful event for you?  37.3 vs. 14.2%  50.0 vs. 28.6% 4.6 vs. 14.3%  9.0 vs. 42.9% 
 Do you have scar pain now?  69.6 vs. 67.7%  21.7 vs. 16.1% 8.7 vs. 16.1% 0 vs. 0% 
 Please evaluate your pain in a scale from 1 to 10  figure 2b 
 Postoperative symptoms/complications 
 No  Yes 
 Did you still have any symptoms similar to 
 these at presentation before surgery? 
 
 100 vs. 100% 
 
 0 vs. 0% 
 UTI  Stones  No 
 Did you have urinary tract infections or 
 recurrent kidney stones in the same side? 
 
 3.7 vs. 13.9% 
 
 0 vs. 0% 
 
 96.3 vs. 86.1% 
 Convalescence 
 At 5 weeks  At 8 weeks 
 When were you completely convalescent?  58.7 vs. 25.8%  87 vs. 71% 
 Return to work 
 At 5 weeks  At 8 weeks 
 When did you return to work?  58.7 vs. 45.1%  93.5 vs. 74.2% 
 Recurrence 
 No  Yes 
 Have you had a re-pyeloplasty operation?  100 vs. 100%  0 vs. 0% 
 Acceptance of the procedure 
 No  Yes  I do not know 
 Did you have a feeling of being ill because of 
 the operation? 
 
 89.1 vs. 83.9% 
 
 4.3 vs. 12.9% 
 
 6.5 vs. 3.2% 
 Follow-up 
 Yes  No 
 Are you satisfied with the follow-up 
 examinations and intervals? 
 
 100 vs. 100% 
 
 0 vs. 0% 
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5 weeks while 93.5 vs. 74.2% returned after 8 weeks, re-
spectively ( fig. 3 ).
 Univariate analysis revealed an advantage to RP over 
OP with a significant difference in five questions related 
to the cosmetic results, scar length, postoperative pains 
and postoperative convalescence results.
 Discussion
 A major aim of any reconstructive surgery is to im-
prove patients’ quality of life. Clinicians often estimate an 
intervention to be successful if it solves the primary ob-






























 Fig. 2. Evaluations of the patients’ answers to some questions of the second questionnaire.  a ‘How much are you satisfied with the cos-
metic results regarding your scars?’  b ‘Please describe your current pains, if present, using the following scale between 0 (no pain) and 





















































 Fig. 3. Evaluations of the patients’ answers to questions of the second questionnaire regarding convalescence and return to work.  a Con-
valescence period: ‘How long did it take after the operation to be again completely (100%) physically normal?’  b ‘When did you returned 




















   
   
   
   
   
   
   
   
   
   
   


























pyeloplasty with objective tests such as postoperative ra-
diography/renography. However, measuring HRQoL can 
add another dimension to the surgical outcomes, provid-
ing patients with the best quality of health care.
 The present study shows for the first time the impact 
of two standard surgical procedures (OP and RP) in terms 
of HRQoL as well as subjective patient evaluation over an 
intermediate follow-up time. Both participating centres 
consider RP as a standard UPJO management. Generally, 
the literature data support that RP combines the highly 
successful OP results and the quick postoperative recov-
ery after laparoscopy  [14–17] .
 Laparoscopic procedures have been associated with 
lower plasma levels of cytokines like IL-1, IL-6, IL-10 and 
CRP compared with conventional resections. The extent 
of this reaction to operative trauma correlates more with 
the approach than with the extent of the procedure. Renal 
surgeries trigger a systemic acute phase reaction which 
can be limited by the laparoscopic access  [18] . These mild 
systemic reactions may be responsible for the rapid post-
operative convalescence  [18, 19] .
 The current surgical and functional outcomes are 
comparable with previous studies  [5–10, 14–17] . Fur-
thermore, RP proved to be superior for intraoperative 
blood loss and early postoperative complications, al-
though operative time was longer. Functional results are 
comparable between the two groups. Importantly, pa-
tients report high HRQoL independent from the tech-
nique used, which is a logical reflection of surgical healthy 
patients. Only 4.3% (RP) vs. 12.9% (OP) of patients had a 
feeling of being ‘slightly ill’ because of the operation.
 There is no known standard questionnaire for the 
evaluation of such cases. The mentioned self-made broad-
spectrum questionnaire was designed to evaluate all op-
eration-related aspects in these patients. Generally, RP 
patients reported better results in all evaluated aspects 
(cosmetic, postoperative pain (early/current), convales-
cence, return to work) than OP patients. RP patients ex-
pressed their satisfaction with cosmetic results as a clear 
advantage over OP (28.0 vs. 14.0%, respectively). On the 
other hand, 19.4 and 9.7% of OP patients reported their 
frustration regarding scar length (being long and very 
long, respectively) and 22.6 and 23.2% regarding scar lo-
cation (being disturbed and much disturbed, respective-
ly).
 Another advantage for RP was postoperative and 
current (1 year) pains. Early pain was reported by 
8.7% (RP) vs. 22.7% (OP) as ‘strong pain’, while current 
scar pain was reported by 8.7% (RP) vs. 16.1% (OP) pa-
tients.
 A notable benefit is the significant difference in the 
convalescence period. At 5 weeks, 58.7% (RP) vs. 25.8% 
(OP) felt ‘fully convalescent’ again. This was better at 
8 weeks, reaching 87.0% (RP) vs. 71.0% (OP). Accord-
ingly, return to work was reported in 58.7% (RP) and 
45.1% (OP) after 5 weeks postoperatively, while in 93.5% 
(RP) and 74.2% (OP) it was after 8 weeks.
 There was no significant difference in any of the eight 
SF-8 domain scores, although RP revealed superior re-
sults in six domains compared to OP (statistically insig-
nificant). Possible explanations are the timing of the 
HRQoL assessment, small sample size or lack of the cal-
culations’ power provided. Following conventional upper 
urinary tract surgery, complete recovery usually takes 
several weeks to months. With the advent of laparoscopy, 
these times have been significantly shortened  [20] . Ac-
cordingly, the SF-8 questionnaire should have been ad-
ministered at an earlier time point or at different follow-
up time points to observe the gradual improvement in 
physical health.
 Further, comparing the outcomes between open and 
laparoscopic nephrectomy (simple, radical and donor) 
using the postoperative recovery scale (modified SF-36 
for evaluation of post-nephrectomy patients) revealed 
that postoperative HRQoL in both groups did not reach 
baseline values until at least 1 year. Laparoscopic patients 
did better than open surgery patients at each time point 
assessed  [21] . Current 1-year results confirm that HRQoL 
does not seem to be negatively affected in both proce-
dures.
 A previous study evaluating HRQoL after laparoscop-
ic urinary tract surgery for malignant and benign condi-
tions showed no significant difference between pre- and 
postoperative SF-8 evaluations  [22] . However, the patient 
groups were heterogeneous, which limits interpretation 
for specific surgical approaches. In the current series, pa-
tients were asked more detailed questions about surgery 
in order to evaluate all aspects from the patients’ point of 
view.
 The current data support that RP is not only safe, but 
also leads to good postoperative HRQoL. These observa-
tions confirm the minimal invasiveness of RP over OP 
from the patients’ point of view and encourage the addi-
tion of this procedure, as a valuable therapy, to the pre-
operative counselling of patients.
 Patient self-evaluation has been previously reported 
for other postoperative functions to have reliability and 
discriminating power  [23, 24] . Further financial analyses 
will be necessary to quantify the impact of RP on work-
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and employers. However, the current information is of 
outmost value to case managers, patients and clinicians 
aligned on reducing morbidity and hastening early return 
to normal work. There is for sure a financial impact of the 
clearly shown differences in rehabilitation time on the re-
duction of costs and the gain in productivity (for both 
health system and patients work) based on the current 
results for RP.
 The current study has limitations, as for instance the 
difference in the idiosyncrasies of the two national health 
systems. The mixed prospective and retrospective design 
may have allowed for a certain self-selection bias, how-
ever, patients were enrolled in a consecutive series. Fur-
thermore, the nature of the study neither allows for the 
assessment of HRQoL at specified postoperative time 
points nor for evaluations of change from baseline 
HRQoL. Our intention was to demonstrate the patients’ 
subjective evaluations of these standard techniques. In 
addition to small sample size, more questions on satisfac-
tion and regret could have provided more aspects regard-
ing outcomes. This issue needs validation in future pro-
spective studies.
 Despite these limitations, we think that our findings 
are robust. Currently, a prospective randomized trial 
comparing minimally invasive versus open pyeloplasty is 
unethical and not feasible. The studied groups were strict-
ly comparable in all aspects, omitting biases that could 
compromise the broadness of the conclusions reached. 
This was the first time a study addressed outcome mea-
sures from the patients’ point of view.
 However, pain and convalescence are objective feel-
ings which can be differently interpreted by different pa-
tients. Treatment satisfaction is mainly derived from per-
ceived differences between expectations and experience 
 [25] . Expectations of one’s future health state have been 
shown to influence patients’ reported HRQoL  [26] . Thus 
patients who choose the ‘less invasive’ RP may have high-
er expectations for their postoperative HRQoL com-
pared to patients choosing ‘traditional’ surgery. There-
fore, even when they achieve similar functional outcomes 
with better evaluation score results compared to OP pa-
tients, they may still experience a higher level of dissatis-
faction. This could explain the current results showing a 
statistical significance in only five questions between the 
two groups. Based on these results, preoperative patient 
counselling should provide them with realistic expecta-
tions for the postoperative results to avoid dissatisfac-
tion.
 Conclusion
 The follow-up results and patient evaluations revealed 
complete patient satisfaction with RP with a better 
HRQoL versus OP. A loin wound is arguably not neces-
sary for either a successful outcome or patients’ conve-
nience after surgery. Preoperative counselling should in-
clude RP and provide patients with realistic expectations 
for the time after surgery. 
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